Bottom line
What is TNMRX's expense ratio?
TNMRX's expense ratio is 1.78%, or about $178 a year on every $10,000 invested. That is more expensive than 64% of alternatives funds we track (median 1.54%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Feb 24, 2026
TNMRX fee table
| Net expense ratio | 1.78% |
|---|---|
| Gross expense ratio | 2.39% |
| Management fee | 0.5% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.96% |
| Acquired fund fees | 0.43% |
| Fee waiver / reimbursement | -0.61% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 24, 2026
What TNMRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| TNMRX | $181 | $687 | $1,220 | $2,680 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.78% expense ratio costs roughly $92,100 in lost growth, versus about $81,400 for the median alternatives fund (1.54%).